New Drug Approvals

• Scemblix (asciminib) Tablets

  Date of Approval: October 29, 2021
  Treatment for: Chronic Myelogenous Leukemia
  Press Release | Approval History

• Vuity (pilocarpine hydrochloride) Ophthalmic Solution

  Date of Approval: October 28, 2021
  Treatment for: Presbyopia
  Press Release | Approval History

• Susvimo (ranibizumab) Injection for Intravitreal Use via Ocular Implant

  Date of Approval: October 25, 2021
  Treatment for:
  Press Release | Approval History

• Xipere (triamcinolone acetonide) Injection

  Date of Approval: October 22, 2021
  Treatment for: Macular Edema, Uveitis
  Press Release | Approval History

• Zimhi (naloxone hydrochloride) Injection

  Date of Approval: October 15, 2021
  Treatment for: Opioid Overdose
  Press Release | Approval History

• Seglentis (celecoxib and tramadol hydrochloride) Tablets

  Date of Approval: October 15, 2021
  Treatment for: Pain
  Press Release | Approval History

• Tyrvaya (varenicline) Nasal Spray

  Date of Approval: October 15, 2021
  Treatment for: Dry Eye Disease
  Press Release | Approval History

• Rethymic (allogeneic processed thymus tissue-agdc) for Surgical Implantation

  Date of Approval: October 8, 2021
  Treatment for: Congenital Athymia
  Press Release | Approval History

• Tavneos (avacopan) Capsules

  Date of Approval: October 7, 2021
  Treatment for: ANCA-Associated Vasculitis
  Press Release | Approval History